Trending Industry Today: FRONTAGE Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks

July 11th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(LIST1261.HK)$ is trending higher today with 8 constituents up, 1 constituents down and FRONTAGE

Moomoo NewsJul 11 01:10 ET

WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year

SHANGHAI, July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has again been

PR NewswireJul 10 01:30 ET

WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year

SHANGHAI, July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has again been

PR NewswireJul 10 01:30 ET

Hong Kong stock concept tracking | Innovative drug policy released, medical companies will speed up improvement in the second half of the year (with concept stocks).

Recently, several domestic heavyweight innovative drugs have been approved, and heavyweight data has been successively announced by ASCO, ESMO, ADA, and EHA. The negotiation rules for payment-side medical insurance tend to be clear and mild, and the regulatory side promotes the industry around clinical value. Domestic new drugs have entered the 2.0 era.

Zhitong FinanceJul 8 20:58 ET

Hong Kong stock market concept tracking | Heavy policies supporting the development of innovative drugs are introduced! The industry is expected to enter the fast lane of development (with concept stocks).

On July 5th, the State Council's executive meeting discussed and deployed the work related to promoting high-quality development of the digital economy, and approved the Implementation Plan for Supporting the Development of Innovative Drugs throughout the Whole Chain.

Zhitong FinanceJul 7 19:05 ET

Hong Kong stock market anomaly | CRO concept stocks collectively rose in the afternoon. The Fed's interest rate hiking cycle is nearing its end, and overseas CXO demand is expected to improve first.

Afternoon rally in CRO concept stocks, as of press time, Tigermed (03347) rose 9.85% to HKD 29.55; Frontage (01521) rose 6.58% to HKD 0.81; Pharmaron (03759) rose 4.72% to HKD 8.65; Asymchem Laboratories (06821) rose 2.47% to HKD 47.65; Wuxi Bio (02269) rose 1.97% to HKD 11.4.

Zhitong FinanceJul 5 02:16 ET